ClinicalTrials.gg
RecruitingNCT03036319PCNUpdated Jan 14, 2026

Patient-Centered NeuroRehabilitation (PCN)

An interventional study of Active tDCS and Sham tDCS in Cognitive Deficit, sponsored by University of Michigan. Recruiting at 1 site in United States. Open to participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-14.

Sponsored by University of Michigan · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
500
Allocation
Non-randomized
Ages
50 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 148 studies in Cognition Disorders with a site in United States — 21 open to participants now, 27 under way, none of them phase 3. Cognition Disorders · United States.

Planned enrollment
7th of 114
500 · median 72
Started
2016
with 10 others
No phase
56 of 148
12 open now
Primary completion
2027-11
later than 15 of 26 live
Registered
99th of 148
by date

Among the 148 studies in Cognition Disorders with a site in United States, this one is the 7th largest by planned enrollment of the 114 interventional ones that give a count, is one of 11 that started in 2016, is one of 56 with no phase, reaches primary completion later than 15 of the 26 other live ones, and was the 99th registered.

Cognition Disorders

399 studies on the registry are indexed under Cognition Disorders; 72 are open to participants now.

Browse Cognition Disorders studies →

Open to participants now

21 of the 148 studies in Cognition Disorders with a site in United States are open now. Recruiting first, the newest first:

15 more — sign in →

All 21 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 46 Cognition Disorders studies recruiting now, 20 (43%) set no upper age limit and 11 (24%) stop at 75 or younger; 5 take children under 18; 13 take healthy volunteers.

This study: 50 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 148 studies in Cognition Disorders with a site in United States, or all of them as a file.
02

Study summary

As individuals grow older, a number of factors can reduce our cognitive (or thinking) abilities such as "normal" aging, neurodegenerative diseases, and cardiovascular disease. This study will evaluate whether cognitive rehabilitation and transcranial electrical stimulation (TES) can improve cognitive abilities. Cognitive rehabilitation refers to methods that are used to improve tasks people have trouble doing in everyday life. Transcranial electrical stimulation uses small amounts of electricity to try to alter brain functioning. These approaches may help improve cognitive abilities like attention, learning, memory, finding words, and problem solving as well as everyday functioning. The goal of this study is to identify how to best use these methods, either alone or in combination.

Read the detailed description

The primary objective of this study is to evaluate the feasibility of a neurorehabilitation treatment tailored to individual patient needs, with the ultimate goal of maximizing cognitive and real-world functioning for older adults with cognitive aging, mild cognitive impairment (MCI), neurodegenerative, or other neurological diseases/conditions.

Transcranial electrical stimulation (TES) is a non-invasive, neurorehabilitation procedure in which a weak electric current is passed between electrodes that are placed on the scalp with the intention of modulating excitability of the underlying brain regions. Because the field of TES is relatively young, rapidly evolving, and primarily focused on cognitive neuroscience with "healthy" individuals, there is a clear need for well-conceptualized and conducted clinical research. The current protocol is intentionally broad with respect to both methodology and patient characteristics in order to tailor potential TES interventions to individual patients or small samples. The current protocol utilizes various forms of TES including transcranial direct current stimulation (tDCS), alternating current stimulation (tACS), and random noise stimulation (tRNS) and sham stimulation in older adults. As this is a cross-over design, some participants may receive active (or "real") TES and/or sham TES conditions.This includes head to head comparisons of the different forms of TES. Additionally, TES could be performed in conjunction with cognitively-based intervention since this may enhance the neuroplastic response of the targeted brain region(s) while at the same time shaping/optimizing the pathways that are engaged by cognitively-based interventions. This broad approach is important since etiological differences in cognitive impairment may necessitate distinct interventions.

03

Conditions studied

  • Cognitive Deficit

Browse trials for

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Individuals who have reported cognitive dysfunction and cognitively intact participants.
  2. Participants will be age 50 or older

Exclusion criteria

Exclusion Criteria:

  1. A history of epilepsy
  2. Sensory or motor impairments that limit the ability to take part in the study
  3. Current alcohol or drug abuse/dependence
  4. Those who are currently pregnant or may become pregnant during the duration of the study (if there is a question of pregnancy, pregnancy tests will be available for participants at no charge)

Those who are being evaluated for TES methodology will also be excluded for 1) metallic or electronic implant 2) skull plates or other cranial implants that affect TES

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
500 participants (estimated)

Study arms

  • Experimental
    Active TES

    Participants will receive "real" tES (tDCS, tACS, tRNS) in which they receive up to 4 milliamps (mA) of stimulation per electrode for up to 40 minutes for up to 260 sessions. As this may be a cross-over design, some participants may receive active and sham conditions.

    Device: Active tDCS · Device: Active tACS · Device: Active tRNS

  • Placebo comparator
    Sham TES

    Participants undergoing this condition will have the exact same procedures as the active group, with the exception that they will receive only sham stimulation for up to 260 sessions.

    Device: Sham tDCS · Device: Sham tACS · Device: Sham tRNS

  • Experimental
    Cognitively based intervention

    Participants may receive a cognitively based intervention that targets the particular cognitive and/or functional abilities of interest. This includes methods of cognitive training, cognitive remediation, and cognitive rehabilitation.

    Behavioral: Cognitively based intervention

  • Experimental
    Active TES + Cognitively based intervention

    This condition combines active TES and cognitively based interventions for some or all of the study sessions

    Device: Active tDCS · Behavioral: Cognitively based intervention · Device: Active tACS · Device: Active tRNS

  • Experimental
    Sham TES + Cognitively based intervention

    This condition combines sham TES and cognitively based interventions for some or all of the study sessions

    Device: Sham tDCS · Behavioral: Cognitively based intervention · Device: Sham tACS · Device: Sham tRNS

  • Experimental
    Active TES, Sham TES, Cognitively based interventions

    This condition combines active and sham TES with cognitively based interventions using a cross-over design

    Device: Active tDCS · Device: Sham tDCS · Behavioral: Cognitively based intervention · Device: Active tACS · Device: Sham tACS · Device: Active tRNS · Device: Sham tRNS

  • Experimental
    Active and Sham TES

    Participants will receive active and sham TES

    Device: Active tDCS · Device: Sham tDCS · Device: Active tACS · Device: Sham tACS · Device: Active tRNS · Device: Sham tRNS

Interventions

  • DeviceActive tDCS

    Participants will receive active tDCS at up to 4mA per electrode for up to 40 minutes for up to 260 sessions.

  • DeviceSham tDCS

    Participants will receive sham tDCS for up to 260 sessions

  • BehavioralCognitively based intervention

    Participants may receive a cognitively based intervention that targets the particular cognitive and/or functional abilities of interest. This includes methods of cognitive training, cognitive remediation, and cognitive rehabilitation for up to 260 sessions

  • DeviceActive tACS

    Participants will receive active transcranial alternating current stimulation at up to 4mA per electrode for up to 40 minutes for up to 260 sessions

  • DeviceSham tACS

    Participants will receive sham transcranial alternating current stimulation for up to 260 sessions

  • DeviceActive tRNS

    Participants will receive active transcranial random noise stimulation at up to 4mA per electrode for up to 40 minutes for up to 260 sessions

  • DeviceSham tRNS

    Participants will receive sham transcranial random noise stimulation for up to 260 sessions

06

What researchers measure

Primary outcomes

  1. TES side effect questionnaire

    Side effect questionnaire that asks participants to rate the severity of potential TES related side effects

    Time frame: Immediately following TES (<15 minutes)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jun 2016, a primary completion of Nov 2027 and a completion of Nov 2027. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 25, 2017
First posted
Jan 30, 2017
Start
Jun 2016
Primary completionEst.
Nov 2027
CompletionEst.
Nov 2027
Last update
Jan 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03036319
Responsible party
Benjamin Hampstead, PhD (Investigator, University of Michigan) — Principal investigator
First posted
Jan 30, 2017
Start date
Jun 2016
Primary completion
Nov 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Jan 14, 2026

Study contacts

Kayla Rinna, M.S.
Contact
krinna@med.umich.edu
734-936-7739
Eileen Robinson, RN, MPH
Contact
robinsoe@med.umich.edu
734-763-1356
Benjamin M Hampstead, Ph.D.
principal investigator · University of Michigan

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion